146 related articles for article (PubMed ID: 12134610)
1. Histologic precursors of gastrointestinal tract malignancy.
Haber MM
Gastroenterol Clin North Am; 2002 Jun; 31(2):395-419. PubMed ID: 12134610
[TBL] [Abstract][Full Text] [Related]
2. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
3. The pathology of epithelial pre-malignancy of the gastrointestinal tract.
Guindi M; Riddell RH
Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):191-210. PubMed ID: 11355911
[TBL] [Abstract][Full Text] [Related]
4. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
5. Neoplasia without dysplasia: lessons from Barrett esophagus and other tubal gut neoplasms.
Odze RD; Maley CC
Arch Pathol Lab Med; 2010 Jun; 134(6):896-906. PubMed ID: 20524867
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and grading of dysplasia in Barrett's oesophagus.
Odze RD
J Clin Pathol; 2006 Oct; 59(10):1029-38. PubMed ID: 17021130
[TBL] [Abstract][Full Text] [Related]
7. Low-grade dysplasia component in early invasive squamous cell carcinoma of the esophagus.
Shimizu Y; Yoshida T; Kato M; Hirota J; Ono S; Nakagawa M; Kobayashi T; Kubota K; Asaka M
J Gastroenterol Hepatol; 2010 Feb; 25(2):314-8. PubMed ID: 19968747
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
9. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus.
Sharma P; Weston AP; Topalovski M; Cherian R; Bhattacharyya A; Sampliner RE
Gut; 2003 Jan; 52(1):24-7. PubMed ID: 12477754
[TBL] [Abstract][Full Text] [Related]
10. Dysplasia in the gastrointestinal tract.
Geboes K
Hepatogastroenterology; 1999; 46(26):657-60. PubMed ID: 10370592
[TBL] [Abstract][Full Text] [Related]
11. Histopathology of early esophageal carcinoma and squamous epithelial dysplasia.
Kuwano H; Baba K; Ikebe M; Adachi Y; Toh Y; Sugimachi K
Hepatogastroenterology; 1993 Jun; 40(3):222-5. PubMed ID: 8325586
[TBL] [Abstract][Full Text] [Related]
12. Squamous dysplasia and other precursor lesions related to esophageal squamous cell carcinoma.
Shimizu M; Ban S; Odze RD
Gastroenterol Clin North Am; 2007 Dec; 36(4):797-811, v-vi. PubMed ID: 17996791
[TBL] [Abstract][Full Text] [Related]
13. Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia.
Duits LC; van der Wel MJ; Cotton CC; Phoa KN; Ten Kate FJW; Seldenrijk CA; Offerhaus GJA; Visser M; Meijer SL; Mallant-Hent RC; Krishnadath KK; Pouw RE; Tijssen JGP; Shaheen NJ; Bergman JJGHM
Gastroenterology; 2017 Apr; 152(5):993-1001.e1. PubMed ID: 28012849
[TBL] [Abstract][Full Text] [Related]
14. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies.
Downs-Kelly E; Mendelin JE; Bennett AE; Castilla E; Henricks WH; Schoenfield L; Skacel M; Yerian L; Rice TW; Rybicki LA; Bronner MP; Goldblum JR
Am J Gastroenterol; 2008 Sep; 103(9):2333-40; quiz 2341. PubMed ID: 18671819
[TBL] [Abstract][Full Text] [Related]
15. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.
Skacel M; Petras RE; Gramlich TL; Sigel JE; Richter JE; Goldblum JR
Am J Gastroenterol; 2000 Dec; 95(12):3383-7. PubMed ID: 11151865
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic significance of nuclear p53 expression in the surveillance of Barrett's esophagus--a longitudinal study.
Klump B; Hsieh CJ; Holzmann K; Borchard F; Gaco V; Greschniok A; Eckardt VF; Bettendorf U; Gregor M; Porschen R
Z Gastroenterol; 1999 Oct; 37(10):1005-11. PubMed ID: 10549095
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of immunohistochemistry in pre-malignant lesions of the gastrointestinal tract.
Ma C; Pai RK
Semin Diagn Pathol; 2015 Sep; 32(5):334-43. PubMed ID: 25749205
[TBL] [Abstract][Full Text] [Related]
18. Dysplasia discrimination in intestinal-type neoplasia of the esophagus and colon via digital image analysis.
Martin DR; Braxton DR; Farris AB
Virchows Arch; 2016 Oct; 469(4):405-15. PubMed ID: 27492044
[TBL] [Abstract][Full Text] [Related]
19. Neoplastic precursor lesions in Barrett's esophagus.
Hornick JL; Odze RD
Gastroenterol Clin North Am; 2007 Dec; 36(4):775-96, v. PubMed ID: 17996790
[TBL] [Abstract][Full Text] [Related]
20. Barrett's oesophagus: from metaplasia to dysplasia and cancer.
Fléjou JF
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i6-12. PubMed ID: 15711008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
